About Edward Sitar
Edward Sitar is a chief financial officer at PreciseDx.
Edward Sitar reports to the SEC as a director or officer of 3 public companies: Timber Pharmaceuticals (TMBR), 9 Meters Biopharma (NMTR) and Vyant Bio (VYNT).
Edward Sitar first appears on SEC filings in 2014.
Experience
This experience comes from Edward Sitar's profile and from SEC filings. For roles taken from filings, the years are when the filings name Edward Sitar in the role, so the role may have started earlier or lasted longer.
PreciseDx, Inc. Current
Chief Financial Officer
2024 – Present · New York, NY
Breast cancer recurrence risk assessments for clinical care teams.
VA
Variantyx
Chief Financial Officer
2022 – 2024
TI
Timber Pharmaceuticals, Inc.
Lead Independent Director and Audit Committee Chair
2020 – 2024 · Public company (TMBR)
9I
9 Meters Biopharma, Inc.
Chief Financial Officer
2019 – 2022 · Public company (NMTR)
CI
CareDox, Inc.
Acting Chief Financial Officer
2019
AL
Ammon Analytical Laboratory
Chief Financial Officer
2017 – 2018
CI
Cancer Genetics, Inc.
Chief Financial Officer
2014 – 2017
VI
Vyant Bio, Inc.
Chief Financial Officer
2014 – 2016 · Public company (VYNT)
HC
Healthagen, an Aetna Company
CFO - New Business
2013
AM
ActiveHealth Management
CFO
2010 – 2012
CI
Cadent Holdings, Inc
Executive Vice President and Chief Financial Officer
2001 – 2011
BC
Bioscrip (Formerly MIM Corp)
CFO
1998 – 2001
VI
Vital Signs, Inc
Vice President - Finance
1996 – 1998
ZI
Zenith/Goldline Pharmaceuticals, Inc
Controller
1993 – 1996
PL
PWC (Coopers & Lybrand)
Senior Manager, Emerging Business Service Team
1982 – 1993
Key Colleagues at Startups
The people Edward Sitar works with at each company, as listed on that company's latest Form D.
PreciseDx, Inc. · Form D, Oct 7, 2026
Eric Converse
Chief Executive Officer and director
Molly Harper
Director
Paul Roma
Chairman
WD
Westley Dupray
Director
EL
Erik Lium
Director
MJ
Michael Hennessy Jr.
Director